Welcome to the Dr. Shaomeng Wang Lab

On Dr. Wang's Lab Website please take a look at our Research, Publications & Lab Members.

Please Contact Us if you would like to know more about our research!

Dr. Shaomeng Wang received his BS in Chemistry from Peking University in 1986 and his PhD in Chemistry from Case Western Reserve University in 1992. Dr. Wang did his postdoctoral training in drug design at the National Cancer Institute, NIH between 1992-1996. Dr. Wang was Assistant Professor at Georgetown University from 1996-2000 and Associate Professor from 2000-2001. Dr. Wang joined the faculty at the University of Michigan Medical School as a tenured Associate Professor in 2001 and was promoted to Professor in 2006. Dr. Wang was named the Warner-Lambert/Parke-Davis Professor in Medicine in 2007. Dr. Wang serves as the Co-Director of the Molecular Therapeutics Program at the University of Michigan Comprehensive Cancer Center and is the Director of the Cancer Drug Discovery Program at the University of Michigan.

Dr. Wang is the Editor-in-Chief for Journal of Medicinal Chemistry, a premier international journal in medicinal chemistry and drug discovery by the American Chemical Society and serves on the editorial board for several international journals.

Dr. Shaomeng Wang has published 300+peer-reviewed papers and an inventor of 50+ issued US patents and hundreds of international patents. He was elected as Fellow of the National Academy of Inventors in 2014 and as Fellow of the American Association for the Advancement of Science (AAAS) in 2019, was induced into Hall of Fame of the Division of Medicinal Chemistry of American Chemical Society in 2020.

Dr. Wang was the 2014 University of Michigan Distinguished Innovator.

In addition to his academic role, Dr Wang is a co-founder of Ascenta Therapeutics and Ascentage Pharma, which were established to develop innovative anticancer medicines with technologies licensed mainly from the University of Michigan.